Related references
Note: Only part of the references are listed.Carvedilol (CAR) combined with carnosic acid (CAA) attenuates doxorubicin-induced cardiotoxicity by suppressing excessive oxidative stress, inflammation, apoptosis and autophagy
Qiu-Lan Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Anti-Inflammatory Effects of Resveratrol: Mechanistic Insights
Diego de Sa Coutinho et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Enoxaparin attenuates doxorubicin induced cardiotoxicity in rats via interfering with oxidative stress, inflammation and apoptosis
Reem Ali Shaker et al.
BMC PHARMACOLOGY & TOXICOLOGY (2018)
Antioxidant effects of resveratrol in the cardiovascular system
Ning Xia et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Significance of Resveratrol in Clinical Management of Chronic Diseases
Awais Wahab et al.
MOLECULES (2017)
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
Heba Samy Shoukry et al.
PLOS ONE (2017)
Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity
Abdelrahman Ibrahim Abushouk et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Preventive role of carvedilol in adriamycin-induced cardiomyopathy
Rajesh Jhorawat et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2016)
Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
Jun Gu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2015)
Resveratrol Prevents Cardiovascular Complications in the SHR/STZ Rat by Reductions in Oxidative Stress and Inflammation
Rebecca K. Vella et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Protective effect of resveratrol against doxorubicin-induced cardiac toxicity and fibrosis in male experimental rats
Manar Hamed Arafa et al.
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY (2014)
The changes of technetium-99m-labeled annexin-V in delayed anesthetic preconditioning during myocardial ischemia/reperfusion
Hong Xie et al.
MOLECULAR BIOLOGY REPORTS (2014)
Amelioration of doxorubicin-induced cardiotoxicity by resveratrol
Sameer E. Al-Harthi et al.
MOLECULAR MEDICINE REPORTS (2014)
From innovative polymers to advanced nanomedicine: key challenges, recent progress and future perspectives
Jan Feijen et al.
NANOMEDICINE (2013)
Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats
Agadihiremath Viswanatha Swamy et al.
INDIAN JOURNAL OF PHARMACOLOGY (2012)
Administration of resveratrol: What formulation solutions to bioavailability limitations?
A. Amri et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
Yanti Octavia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Combining Nitrous Oxide with Carbon Dioxide Decreases the Time to Loss of Consciousness during Euthanasia in Mice - Refinement of Animal Welfare?
Aurelie A. Thomas et al.
PLOS ONE (2012)
Resveratrol Inhibits Renal Fibrosis in the Obstructed Kidney Potential Role in Deacetylation of Smad3
Jinhua Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Doxorubicin Cardiomyopathy
Kanu Chatterjee et al.
CARDIOLOGY (2010)
Protective effect of carvedilol on daunorubicin-induced cardiotoxicity and nephrotoxicity in rats
Wawaimuli Arozal et al.
TOXICOLOGY (2010)
Resveratrol treatment protects against doxorubicin-induced cardiotoxicity by alleviating oxidative damage
Elif Tatlidede et al.
FREE RADICAL RESEARCH (2009)
Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo
Michihiko Ueno et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method
Irfan Rahman et al.
NATURE PROTOCOLS (2006)
Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro
P Spallarossa et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway
F Romeo et al.
CARDIOVASCULAR RESEARCH (2000)
Share Paper
